Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises EXK Q1 2026 Earnings EPS Smashes Estimates by Nearly 60 Stock Edges Lower FSBW Q1 2026 Earnings Modest EPS Beat Highlights Stability Amid Soft Stock Response CTS Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher ARM Q1 2026 Earnings EPS Beat Amidst Revenue Discrepancy Uncertainty SLB Q1 2026 Earnings Slight EPS Miss Amid Stable Market Sentiment